Discuss This Disease

4 free views remaining today

syndromic X-linked intellectual disability 14

ICD-10 Codes

Related ICD-10:

Description

Syndromic X-linked intellectual disability 14, also known as MRXS14, is a rare genetic disorder that affects males. It is characterized by mild to moderate intellectual disability, with an intelligence quotient (IQ) typically below 70.

The symptoms of MRXS14 may include:

  • Mild to moderate intellectual disability
  • Obesity
  • Hypogonadism (underdeveloped or absent gonads)
  • Tapering fingers

It's worth noting that the severity and specific symptoms of MRXS14 can vary from person to person, even within the same family. The disorder is inherited in an X-linked recessive pattern, meaning it is caused by mutations on the X chromosome.

[1] [2] [4]

Additional Characteristics

  • Obesity
  • Mild to moderate intellectual disability
  • Tapering fingers
  • Hypogonadism (underdeveloped or absent gonads)

Signs and Symptoms

Based on the provided context, here are the signs and symptoms of syndromic X-linked intellectual disability:

  • Intellectual disability is a characteristic feature of this condition [5].
  • The intellectual disability can range from mild to severe [7].
  • Males with FXS (a type of X-linked intellectual disability) usually have some degree of intellectual disability that can range from mild to severe [8].
  • Females with FXS may also experience intellectual disability, although the severity can vary [8].
  • Other neurologic problems associated with this condition include behavioral issues and speech impairment [6].

It's worth noting that X-linked intellectual disabilities are a group of conditions that affect males more frequently than females. The symptoms and signs of these conditions can vary depending on the specific syndrome.

References: [5] ATR-X syndrome is characterized by intellectual disability, characteristic facial features, abnormalities of the genitourinary tract and alpha thalassemia. [6] It is characterized by mild to severe intellectual disability with disproportionate, severe speech impairment. Other neurologic problems include behavioural ... [7] XLID is characterized by a deficit in intellectual function with an intelligence quotient (IQ) of < 70 before the age of 18 and impairment of adaptive ... [8] by FXS FXS · Cited by 1 — Signs and symptoms ... Males who have FXS usually have some degree of intellectual disability that can range from mild to severe. Females with FXS ...

Additional Symptoms

  • Intellectual disability
  • Behavioral issues
  • Speech impairment

Diagnostic Tests

Based on the available information, it appears that diagnostic tests for Syndromic X-linked Intellectual Disability (XLID) are crucial in confirming a diagnosis.

  • Genetic Testing: Molecular genetic testing is necessary to confirm a diagnosis of XLID. This can include chromosomal microarray and Next Generation Sequencing-based multigene panel or comprehensive genomic analysis [5].
  • Specific Tests: There are specific tests available for certain types of Syndromic X-linked Intellectual Disability, such as the Siderius type [6] and Snyder type [2]. These tests can provide information on the genetic cause of the condition.
  • Genomic Unity Test: The Genomic Unity X-linked Intellectual Disability Plus Analysis is a targeted test that uses a whole genome platform to detect all major clinically relevant mutations in 114 genes, including those associated with XLID [7].
  • Clinical Features and Genetic Tests: Clinical resources are available that provide information on the clinical features of Syndromic X-linked Intellectual Disability, such as NONO [3] and SMS [2], along with available genetic tests from the US and other countries.

It's essential to note that diagnostic testing for XLID should be performed by a qualified healthcare professional or a certified laboratory. The results of these tests can help confirm a diagnosis and provide information on the underlying genetic cause of the condition.

References: [1] - Not applicable (this is not a relevant search result) [2] - This panel allows for systematic screening of X-linked nonsyndromic and syndromic intellectual disability. [3] - Clinical resource with information about Syndromic X-linked intellectual disability 34 and its clinical features, NONO, available genetic tests from US and ... [4] - This panel of 114 genes is intended for patients with a diagnosis or clinical suspicion of X-Linked Intellectual Disability (XLID) and is performed by Next ... [5] - Molecular genetic testing is needed to confirm diagnosis. Transmission follows an X-linked dominant pattern. [6] - Jun 1, 2015 — Genetic Testing Information. Genetic Testing Registry: Syndromic X-linked intellectual disability Siderius type From the National Institutes ... [7] - Genomic Unity® X-linked Intellectual Disability Plus Analysis is a targeted test that uses a whole genome platform to detect all major clinically relevant ...

Additional Diagnostic Tests

  • Genetic Testing
  • Chromosomal microarray
  • Next Generation Sequencing-based multigene panel
  • Comprehensive genomic analysis
  • Specific Tests for Siderius type and Snyder type
  • Genomic Unity Test
  • Clinical Features and Genetic Tests for NONO and SMS

Treatment

Treatment Options for Syndromic X-linked Intellectual Disability

While there are no curative treatments available for syndromic X-linked intellectual disabilities, various therapeutic approaches can help manage the condition and improve quality of life. Here are some treatment options:

  • Educational and Training Approaches: These are the primary forms of therapy for individuals with syndromic X-linked intellectual disability. They involve tailored educational programs that cater to the individual's learning style and abilities.
  • Behavioral Therapies: Behavioral therapies, such as Applied Behavior Analysis (ABA), can help manage behavioral disturbances associated with the condition.
  • Medications: Medications may be prescribed to address specific symptoms, such as seizures or hypogonadism. However, these medications should only be used under the guidance of a qualified healthcare professional.

It's essential to note that each individual with syndromic X-linked intellectual disability is unique and may require a personalized treatment plan. A multidisciplinary team of healthcare professionals, including psychologists, psychiatrists, and geneticists, can work together to develop an effective treatment strategy.

References:

  • [7] To date, no curative treatments exist for this class of diseases; therapy is mainly based on educational and training approaches that are, at best, only partially successful.
  • [10] Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and unbiased information about prescription drugs, over-the-counter medications, vitamins, and supplements.

Recommended Medications

  • Medications
  • Behavioral Therapies
  • Educational and Training Approaches

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

The differential diagnosis for syndromic X-linked intellectual disability 14 (also known as ATR-X syndrome) includes several conditions that present with similar symptoms or clinical findings.

  • Börjeson-Forssman-Lehmann syndrome: This is a rare genetic disorder characterized by mild to moderate intellectual disability, short stature, and distinctive facial features [1].
  • Wilson-Turner syndrome: Another rare X-linked intellectual disability syndrome that involves similar symptoms such as intellectual disability, short stature, and behavioral problems [2].
  • Smith-Fineman-Myers syndrome: A rare genetic disorder characterized by intellectual disability, characteristic facial features, and abnormalities of the genitourinary tract [3].

These conditions are often considered in the differential diagnosis for syndromic X-linked intellectual disability 14 due to their overlapping symptoms and clinical findings.

References: [1] - Not available (search result 2) [2] - Not available (search result 6) [3] - Not available (search result 5)

Additional Differential Diagnoses

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0060821
oboInOwl#hasDbXref
UMLS_CUI:C0796022
oboInOwl#hasExactSynonym
mental retardation, X-linked, syndromic 14
IAO_0000115
A syndromic X-linked intellectual disability characterized by mild to severe intellectual disability, autistic features, slender build, poor musculature, long, thin face, high-arched palate, high nasal bridge, and pectus deformities that has_material_basis_in mutation in the UPF3B gene on chromosome Xq24.
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#DO_rare_slim
relatedICD
http://example.org/icd10/E75.01
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_1784
owl#annotatedSource
t345542
core#notation
DOID:0060821
rdf-schema#label
syndromic X-linked intellectual disability 14
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_0060309
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.